Your browser doesn't support javascript.
loading
Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2.
Sethi, Ashish; Bruell, Shoni; Ryan, Tim; Yan, Fei; Tanipour, Mohammad Hossein; Mok, Yee-Foong; Draper-Joyce, Chris; Khandokar, Yogesh; Metcalfe, Riley D; Griffin, Michael D W; Scott, Daniel J; Hossain, Mohammad Akhter; Petrie, Emma J; Bathgate, Ross A D; Gooley, Paul R.
Afiliación
  • Sethi A; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3052, Australia.
  • Bruell S; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3052, Australia.
  • Ryan T; Australian Nuclear Science Technology Organisation, The Australian Synchrotron, 800 Blackburn Rd, Clayton, Victoria 3168, Australia.
  • Yan F; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3052, Australia.
  • Tanipour MH; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3052, Australia.
  • Mok YF; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3052, Australia.
  • Draper-Joyce C; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3052, Australia.
  • Khandokar Y; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3052, Australia.
  • Metcalfe RD; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3052, Australia.
  • Griffin MDW; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3052, Australia.
  • Scott DJ; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3052, Australia.
  • Hossain MA; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3052, Australia; School of Chemistry, The University of Melbourne, Parkville, Victoria 3052, Australia.
  • Petrie EJ; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3052, Australia; Florey Institute of Neuroscience and Mental Health, The University o
  • Bathgate RAD; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria 3052, Australia. Electronic address: bathgate@florey.edu.au.
  • Gooley PR; Department of Biochemistry & Pharmacology, The University of Melbourne, Parkville, Victoria 3052, Australia; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria 3052, Australia. Electronic address: prg@unimelb.edu.au.
J Mol Biol ; 433(21): 167217, 2021 10 15.
Article en En | MEDLINE | ID: mdl-34454945
ABSTRACT
Our poor understanding of the mechanism by which the peptide-hormone H2 relaxin activates its G protein coupled receptor, RXFP1 and the related receptor RXFP2, has hindered progress in its therapeutic development. Both receptors possess large ectodomains, which bind H2 relaxin, and contain an N-terminal LDLa module that is essential for receptor signaling and postulated to be a tethered agonist. Here, we show that a conserved motif (GDxxGWxxxF), C-terminal to the LDLa module, is critical for receptor activity. Importantly, this motif adopts different structures in RXFP1 and RXFP2, suggesting distinct activation mechanisms. For RXFP1, the motif is flexible, weakly associates with the LDLa module, and requires H2 relaxin binding to stabilize an active conformation. Conversely, the GDxxGWxxxF motif in RXFP2 is more closely associated with the LDLa module, forming an essential binding interface for H2 relaxin. These differences in the activation mechanism will aid drug development targeting these receptors.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Relaxina / Receptores de Péptidos / Receptores Acoplados a Proteínas G Límite: Humans Idioma: En Revista: J Mol Biol Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Relaxina / Receptores de Péptidos / Receptores Acoplados a Proteínas G Límite: Humans Idioma: En Revista: J Mol Biol Año: 2021 Tipo del documento: Article País de afiliación: Australia